Get the Stockscreener App
0.9699
10.22%
0.0899
Estrella Immunopharma Inc stock is traded at $0.9699, with a volume of 4,629.
It is up +10.22% in the last 24 hours and up +10.97% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$0.88
Open:
$0.8975
24h Volume:
4,629
Relative Volume:
0.03
Market Cap:
$35.95M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-3.233
EPS:
-0.3
Net Cash Flow:
$-18.01M
1W Performance:
+6.58%
1M Performance:
+10.97%
6M Performance:
-34.47%
1Y Performance:
-26.52%
1-Day Range:
$0.8801
$0.9699
1-Week Range:
$0.88
$0.9853
52-Week Range:
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.9699 | 34.08M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
Is Estrella Immunopharma Inc. stock bottoming outPortfolio Update Report & Free Risk Controlled Daily Trade Plans - Newser
Detecting price anomalies in Estrella Immunopharma Inc. with AIWeekly Trade Review & AI Driven Price Predictions - Newser
Estrella Immunopharma Faces Nasdaq Non-Compliance Notice - MSN
Should you wait for a breakout in Estrella Immunopharma Inc.July 2025 EndofMonth & Intraday High Probability Alerts - Newser
Estrella Immunopharma Inc. Reaches Critical Trendline SupportJuly 2025 Gainers & Proven Capital Preservation Tips - classian.co.kr
What earnings revisions data tells us about Estrella Immunopharma Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
Custom watchlist performance reports with Estrella Immunopharma Inc.July 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
Does Estrella Immunopharma Inc. fit your quant trading modelMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Will Estrella Immunopharma Inc. price bounce be sustainableJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Using RSI to spot recovery in Estrella Immunopharma Inc.2025 Growth vs Value & Long-Term Growth Plans - Newser
Is Estrella Immunopharma Inc. forming a bottoming base2025 Big Picture & Real-Time Price Movement Reports - Newser
Can technical indicators confirm Estrella Immunopharma Inc.’s reversalIPO Watch & Accurate Technical Buy Alerts - Newser
Using data tools to time your Estrella Immunopharma Inc. exitInsider Selling & Low Risk High Win Rate Stock Picks - Newser
Published on: 2025-08-19 07:40:51 - 선데이타임즈
What machine learning models say about Estrella Immunopharma Inc.Quarterly Portfolio Review & Reliable Entry Point Alerts - Newser
Will Estrella Immunopharma Inc. benefit from macro trendsJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Estrella Immunopharma Inc. Stock Support and Resistance Levels You Should Know2025 Sector Review & Technical Confirmation Trade Alerts - Newser
How high can Estrella Immunopharma Inc. stock go2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Should you hold or exit Estrella Immunopharma Inc. nowProduct Launch & Low Drawdown Momentum Trade Ideas - Newser
Understanding Estrella Immunopharma Inc.’s price movementTrade Analysis Report & Short-Term Trading Opportunity Alerts - Newser
Published on: 2025-08-17 09:45:59 - metal.it
Analyzing Estrella Immunopharma Inc. with risk reward ratio chartsCPI Data & Accurate Entry and Exit Point Alerts - Newser
Why Estrella Immunopharma Inc. stock attracts strong analyst attentionWeekly Trend Summary & Target Return Focused Picks - Newser
Is Estrella Immunopharma Inc. forming a reversal patternJuly 2025 Levels & Verified Chart Pattern Trade Signals - Newser
Analyzing recovery setups for Estrella Immunopharma Inc. investorsMarket Risk Analysis & Growth Focused Stock Reports - Newser
How Estrella Immunopharma Inc. stock performs during market volatilitySell Signal & Smart Allocation Stock Tips - Newser
Competitive Positioning of Estrella Immunopharma Inc.: Is It Leading or Lagging2025 Top Decliners & Daily Profit Focused Screening - Newser
What moving averages say about Estrella Immunopharma Inc.July 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Is Estrella Immunopharma Inc. benefiting from interest rate changes2025 Market Overview & Capital Protection Trading Alerts - sundaytimes.kr
Is Estrella Immunopharma (NASDAQ:ESLA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):